| Market Cap (cr): | ₹78.7 Cr | Book Value: | ₹50.8 |
|---|---|---|---|
| Lot Size: | 100 shares | 52 Week High: | ₹350 |
| 52 Week Low: | ₹163 | EPS: | ₹15.6 |
| Demat Account: | PB: | 4.25 | |
| Face Value: | ₹10 | Debt To Equity: | 0.06 |
| No Of Shares: | 36,42,000 | Url: |
Overview :
Company Overview
Merind Limited, founded in 1958, is a legacy pharmaceutical and APIs (Active Pharmaceutical Ingredients) company headquartered in Mumbai. Now a privately held entity after delisting in 2005 (via amalgamation), Merind has a strong track record in key pharma sectors, consistently posting robust profit margins and maintaining a stable balance sheet. The company stands out for its experience in formulation and generics manufacturing, lean operations, and focus on capital stewardship—making it a unique long-term value play in India’s pharma ecosystem.
Merind operated in Indian pharmaceuticals during a period of substantial industry transformation. The sector's history from the 1970s onward was shaped by:
- The Patents Act 1970, which permitted process patents only — enabling Indian companies to reverse-engineer drugs and build a generics industry
- Drug price control under the DPCO, which constrained margins on essential medicines
- Consolidation from the 1990s onward, as larger Indian and multinational companies acquired smaller manufacturers to gain products, plants and market access
- The 2005 product patent regime, which fundamentally reshaped the industry
Many mid-size Indian pharmaceutical companies of that era were acquired and absorbed — which is why entity verification is essential when dealing with shares from that period.
FAQs
What is the current status of Merind Limited shares?
This must be verified before transacting. Merind has a complex corporate history involving ownership changes and restructuring. Call Arms Securities at +91-8882245112 and we will confirm the exact entity, its CIN, whether it is active, merged or dissolved, and whether shares are genuinely available and transferable.
What was Merind Limited?
Merind was an Indian pharmaceutical company, historically associated with the Tata group's pharmaceutical interests and subsequently with Wockhardt. Its exact current corporate position requires verification.
I hold Merind share certificates. What should I do?
Call +91-8882245112. Arms Securities specialises in physical certificates, merged entities, dormant companies and transmission cases. We will verify what your holding represents today, authenticate the certificates, handle transmission if the shares were inherited, assist with dematerialisation where possible, and tell you honestly whether a realisable value exists.
Can I still buy Merind shares?
Only if the entity is active and shares are genuinely transferable — which must be verified first. Call Arms Securities at +91-8882245112 before committing any funds. We would rather spend ten minutes checking than let you buy something that no longer exists in the form you expect.
What happens to shareholders when a company is merged?
It depends on the scheme. You may receive shares in the acquirer at a determined swap ratio, receive cash consideration with your shares extinguished, hold shares in a continuing shell entity, or — if the company was struck off — hold shares with no value at all. Only the actual scheme documents determine which applies.
If my Merind shares have no value, is there anything I can do?
Possibly. Realising a capital loss can be set off against other capital gains under Indian tax law, which has genuine monetary value. Arms Securities can advise on how to formally realise the position, and you should consult a Chartered Accountant on the tax treatment.
+91-8882245112 | contact@armssecurities.com
Physical share assistance → | Delisted shares guide →
Board of Directors
| Name | Designation |
|---|---|
| Huzaifa Habil Khorakiwala | Director |
| Zahabiya Habil Khorakiwala | Director |
| Stephen Sabbas D’souza | Director |
Company Incorporation Details
| Attribute | Details |
|---|---|
| Company Name | Merind Limited |
| CIN | U24239MH1958PLC011204 |
| Date of Incorporation | 4 November 1958 |
| Registered Office | Readymoney Terrace, 2nd Floor, Room 5, 167 Dr. Annie Besant Road, Mumbai – 400018, Maharashtra |
| Face Value | ₹10 |
| ISIN | INE215A01016 |
| Lot Size | 100 shares |
| Demat Account | Mandatory |
Shareholding Pattern (FY2025)
| Category | % Holding |
|---|---|
| Promoter (Dartmour Holdings Pvt Ltd) | 96.06 |
| Public/Other Shareholders | 3.94 |
Sector
- Industry: Pharmaceuticals
- Segment: APIs, Formulations, Heritage Generics
Why Choose Arms Securities?
Trade Merind Limited unlisted shares with confidence—benefiting from transparent pricing, regulatory safety, and true end-to-end support powered by Arms Securities.
Net Sales (in cr.)
Total Income (in cr.)
Operating Profit (in cr.)
Net Profit (in cr.)
Shareholder Funds (in cr.)
Total Assets (in cr.)
Frequently Ask Question